TrialBritish journal of haematology2019

Bortezomib reinduction chemotherapy in high-risk ALL in first relapse: a report from the Children's Oncology Group.

Terzah M Horton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.